Bullseye Biosciences
PrivateLast Round
Seed
Apr 24, 2025
Total Funding Raised
$3M
Company Overview
Bullseye Biosciences operates in Healthcare & Life Sciences and is based in Massachusetts. Its latest recorded funding round was a Seed round in April 2025.
Bullseye Biosciences is a biotechnology company that operates a therapeutics discovery platform using robotics, directed evolution, and sequencing to develop medicines for oncology, immunology, and cardiometabolic diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bullseye Biosciences Comparables
Compare Bullseye Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SyntheX | 84% | |
| Ambagon Therapeutics | 80% | |
| Orbis Medicines | 79% |
For institutional investors. Book with your work email.
Bullseye Biosciences Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Bullseye Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Harvard Innovation Labs | Seed |
| ZAKA VC | Seed |
| Ono Venture Investment, Inc. | Accelerator |
| Mission BioCapital | Seed, Accelerator |
| National Science Foundation | Seed |
| Illumina Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 19, 2026
Grew 100% QoQ from 3 to 6 employees.
- May 4, 2025
Monthly visitors increased 407% MoM.
For institutional investors. Book with your work email.
Bullseye Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Bullseye Biosciences's valuation, stock price, and market status.
Is Bullseye Biosciences a public or private company?
Bullseye Biosciences is a private company.
What is the current stock price of Bullseye Biosciences?
Bullseye Biosciences is a private company, so its shares have no public market price. Caplight tracks Bullseye Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Bullseye Biosciences worth (valuation)?
Valuation information for Bullseye Biosciences is not publicly available.
Can I buy Bullseye Biosciences stock?
Bullseye Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Bullseye Biosciences's last funding round?
Bullseye Biosciences's most recent funding round was Seed on April 24, 2025.
Who are the main investors in Bullseye Biosciences?
Key investors in Bullseye Biosciences include Mission BioCapital.
Will Bullseye Biosciences IPO soon?
No public IPO plans have been announced for Bullseye Biosciences.
How can I track Bullseye Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Bullseye Biosciences's shares on secondary markets.